CTDH Projected Dividend Yield
CTD Holdings Inc (FL) ( OTCBB : CTDH )Cyclo Therapeutics a biotechnology company that develops cyclodextrin-based products for the treatment of disease. Co.'s drug candidate, Trappsol® Cyclo™ (hydroxypropyl beta cyclodextrin), is used as a treatment for Niemann-Pick Type C disease (NPC). NPC is a cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. Co. also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, mainly for use in diagnostics and specialty drugs. Cyclodextrins are molecules that bring together oil and water, making the oily materials soluble in water, and have potential applications anywhere oil and water must be used together. 20 YEAR PERFORMANCE RESULTS |
CTDH Dividend History Detail CTDH Dividend News CTDH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |